Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis
2015 ◽
Vol 60
(3)
◽
pp. 1854-1858
◽
Keyword(s):
This is a retrospective study of 15 difficult-to-treat (i.e., exhibiting previous failure, patient side effects, or resistance to ciprofloxacin and co-trimoxazole) chronic bacterial prostatitis infections (5 patients with multidrug-resistantEnterobacteriaceae[MDRE]) receiving fosfomycin-tromethamine at a dose of 3 g per 48 to 72 h for 6 weeks. After a median follow-up of 20 months, 7 patients (47%) had a clinical response, and 8 patients (53%) had persistent microbiological eradication; 4/5 patients with MDRE isolates achieved eradication. There were no side effects. Fosfomycin-tromethamine is a possible alternative therapy for chronic bacterial prostatitis.
1990 ◽
Vol 73
(4)
◽
pp. 502-512
◽
Keyword(s):
2000 ◽
Vol 14
(2)
◽
pp. 143-149
◽
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 65
(06)
◽
pp. 484-490
◽
1995 ◽
Vol 82
(5)
◽
pp. 745-751
◽
1981 ◽
Vol 55
(3)
◽
pp. 414-419
◽
Keyword(s):